P04.4
Newborn affected by maternal use of drugs of addiction
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 code P04.4 pertains to newborn babies affected by maternal use of drugs of addiction during pregnancy. This condition occurs when a pregnant woman consumes substances such as opioids, cocaine, methamphetamines, or other addictive drugs, which can adversely impact the developing fetus. The effects may be evident immediately after birth and can lead to various health challenges for the newborn. Recognizing and understanding this condition is essential for healthcare providers and new parents to ensure appropriate care and support for affected infants.
Causes & Symptoms
Clinical Causes: Maternal use of opioids, such as heroin or prescription pain medications containing opioids Use of stimulants like cocaine or methamphetamines during pregnancy Consumption of other addictive substances, including alcohol or certain prescription drugs Unintentional exposure to drugs due to environmental or social factors during pregnancy
Key Symptoms: Low birth weight Withdrawal symptoms such as tremors, irritability, and feeding difficulties Respiratory issues, including rapid breathing or apnea Muscle rigidity or abnormal motor movements Sleep disturbances or excessive sleepiness Feeding problems and poor weight gain Persistent vomiting or diarrhea Seizures in severe cases
Diagnostic & Treatment
Diagnosis Path: The diagnosis of a newborn affected by maternal drug use typically involves a thorough examination by healthcare professionals, including observation of withdrawal symptoms shortly after birth. Additional testing such as urine, blood, or meconium analysis may be used to detect the presence of drugs or their metabolites. Prenatal care records and maternal history are also important for identifying potential risks. Screening tools and standardized assessment protocols help confirm the diagnosis and guide treatment planning.
Treatment Protocols: Gentle supportive care in a specialized neonatal unit to address withdrawal symptoms Medication-assisted treatment, such as morphine or phenobarbital, may be used to ease withdrawal Nutritional support to promote healthy growth and development Monitoring and management of respiratory and cardiovascular stability Providing a calm and safe environment to reduce stress and overstimulation Engagement of social services and developmental specialists to support long-term growth Parental education and counseling to support mothers in recovery and prevent future occurrences
Clinical Advice & FAQs
Billing Guidance
Is P04.4 a billable ICD-10 code?
Yes, P04.4 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report P04.4?
Clinical documentation must specify the nature of Newborn affected by maternal use of drugs of addiction and any associated comorbidities for accurate reporting.
Cite this Clinical Reference